RXRA and primary cutaneous T-cell non-Hodgkin lymphoma: In the RXR transfection assay Bexarotene (LG1069), a rexinoid approved for treating cutaneous T-cell lymphoma [30], displayed an EC50 of 18nM for activation of RXRα (Table 1).